Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax

NCT ID: NCT02987660

Last Updated: 2019-01-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-03

Study Completion Date

2017-07-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare Topography Guided Laser In Situ Keratomileusis (LASIK) corneal surgery to Small Incision Lenticule Extraction (SMILE) corneal surgery for the treatment of myopia with astigmatism.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LASIK with EX500

Topography Guided LASIK with WaveLight EX500 excimer laser system in bilateral surgery

Group Type EXPERIMENTAL

Topography Guided LASIK

Intervention Type PROCEDURE

Corneal surgery for refractive error correction

WaveLight EX500 Excimer Laser System

Intervention Type DEVICE

As used for corneal stroma ablation (refractive error correction). The treatment is intended to last the subject's lifetime.

SMILE with VisuMax

Small incision lenticular extraction (SMILE) with VisuMax laser in bilateral surgery

Group Type ACTIVE_COMPARATOR

Small Incision Lenticular Extraction

Intervention Type PROCEDURE

Refractive surgical procedure for the correction of myopia with or without astigmatism

VisuMax Surgical Laser

Intervention Type DEVICE

As used for lenticule creation/removal (refractive error correction). The treatment is intended to last the subject's lifetime.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Topography Guided LASIK

Corneal surgery for refractive error correction

Intervention Type PROCEDURE

Small Incision Lenticular Extraction

Refractive surgical procedure for the correction of myopia with or without astigmatism

Intervention Type PROCEDURE

WaveLight EX500 Excimer Laser System

As used for corneal stroma ablation (refractive error correction). The treatment is intended to last the subject's lifetime.

Intervention Type DEVICE

VisuMax Surgical Laser

As used for lenticule creation/removal (refractive error correction). The treatment is intended to last the subject's lifetime.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SMILE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects in Singapore must be 21 years of age or older and subjects in Korea must be upon completion of 19 years of age or older due to local regulations;
* Able to comprehend and sign an informed consent form;
* Willing and able to complete all postoperative visits;
* Myopia requiring (a) refractive error correction of -0.5 to -8.0 D optical infinity adjusted manifest refraction sphere with (b) astigmatism correction of -0.75 to -5.0 D manifest refraction cylinder and (c) at least 0.75 D of corneal astigmatism.
* Intended treatment targeted for emmetropia;
* Preoperative best-corrected visual acuity (BCVA) of 0 logMAR or better;

Exclusion Criteria

* Pregnant or lactating, current or planned, during the course of the study;
* Dry eye;
* Corneal disease;
* Diagnosis of advanced glaucoma;
* Uncontrolled diabetes;
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon, a Novartis Company

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alcon, A Novartis Division

Role: STUDY_DIRECTOR

Alcon, A Novartis Division

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alcon Investigative Site

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RFL605-P001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CONTOURA vs WFO Ablation PRK & LASIK
NCT05037370 RECRUITING NA
WaveLight® Refractive Myopic Study
NCT01941498 COMPLETED NA
LASIK iDesign vs SMILE
NCT07126756 ACTIVE_NOT_RECRUITING NA